Frommer Lawrence and Haug

News | Patent | NALP

Rating are based on thousands of associate surveys.

Main Office:
Participating Offices:
Prestige [?]: N/A
Compensation [?]: N/A
Hours worked [?]: N/A
Place to stay [?]: N/A
Lifestyle [?]: N/A
Progression potential [?]: N/A
Diversity commitment [?]: N/A
Pro Bono dedication [?]: N/A
User rating [?]:

Write a comment about this firm and share your views.

Most useful comments (See all comments)

No comments have yet been rated as useful.

Most recent comments (See all comments)

There are no comments.

Ratings principally based on over 6,500 associate surveys (3rd-5th years). See The American Lawyer's 2006 Midlevel Associates Survey.

Firm News

Boston Business Journal
NY law firm expands into Boston with new name and ambitious missionBoston Business JournalThe law firm Frommer Lawrence & Haug revealed Wednesday that it was opening a Boston office and changing its name as part of a major shift from intellectual property specialist to a firm with a much broader scope. The firm's new office is at One Post …and more »
Law Firm Frommer Lawrence & Haug Unifies Brand – Becomes Haug Partners and Announces ExpansionYahoo FinanceEmbarking on a new era of growth, Frommer Lawrence & Haug LLP today announced that it will change its name to Haug Partners LLP, effective immediately. Co-Founder and Managing Partner Ed Haug unveiled the new name as he revealed the firm's plan ...and more »
Frommer Lawrence Nabs Ex-DLA Piper Life Sciences AttyLaw360 (subscription)A former DLA Piper partner, who has represented clients such as pharmaceutical companies Genzyme Corp. and Pfizer Inc. in drug liability and other litigation, has joined Frommer Lawrence & Haug LLP to co-chair its life sciences practice, the firm said …Frommer Lawrence & Haug Expands Services with Hire of Litigator John C. DoughertyBusiness Wire (press release)all 6 news articles »
Patent Vet Jumps From Frommer Lawrence To Garson SegalLaw360 (subscription)Kevin F. Murphy joined Garson Segal as a partner after 14 years with Frommer Lawrence, where he developed a particular expertise in pharmaceutical patent litigation, handling major cases for generics giants like Actavis PLC, Lupin Pharmaceuticals Inc.
Frommer, Lawrence & Haug Partner Ed Haug Fails to Fill "Communication Vacuum" Created by "The Patent '813 Story ...PR Newswire (press release)The development takes place as Frommer, Lawrence & Haug partner Ed Haug failed to fill a "communication vacuum" explained to him earlier in the day in an email communication. This press release that you are now reading, issued by the company, is the ...
Paulick Report
Newcomer Best Buys Pair Of Million-Dollar-Plus Juveniles From Frommer At Fasig-Tipton Gulfstream SalePaulick ReportCary Frommer hit two massive pinhooking home runs in 2016 with a pair of colts by Ashford Stud's hot young sire Uncle Mo. A $190,000 yearling purchase sold for $1 million at Gulfstream Park in Hallandale Beach, Fla., during Fasig-Tipton's 2-year-olds …and more »
FLH Successfully Defends Shire's Patents Covering Blockbuster Drug Vyvanse®Lexology (registration)Frommer Lawrence & Haug LLP (FLH) represented Shire before the District Court and the U.S. Court of Appeals for the Federal Circuit in lawsuits against five generic pharmaceutical manufacturers that filed Abbreviated New Drug Applications (ANDAs) with ...
An Attorney Wish List For The Next USPTO DirectorLaw360 (subscription)Law360, New York (January 18, 2017, 3:23 PM EST) -- From managing the influx of America Invents Act petitions to grappling with emerging case law on patent eligibility, the next director of the U.S. Patent and Trademark Office will have a packed agenda.and more »
Medicines Co. Gets Fed. Circ. Grilling On Blood Thinner IPLaw360 (subscription)Law360, Washington (December 6, 2016, 3:31 PM EST) -- Members of a Federal Circuit panel questioned whether The Medicines Co. could hold onto one of its patents on the blood thinning drug Angiomax Tuesday, wondering whether the patent was so ...
Shire Prevails In Patent Trial Over Mylan's Generic LialdaLaw360 (subscription)Law360, New York (January 27, 2017, 8:45 PM EST) -- Following a four-day bench trial held in September, a Florida federal judge concluded on Friday that Mylan Pharmaceuticals Inc.'s proposed generic version of Shire Development LLC's bowel disease ...and more »
Valid XHTML 1.0 Transitional
Valid CSS!